APA (7th ed.) Citation

Prabhash, K., Patil, S., Malik, P. S., Mallavarapu, K. M., Kilara, N., Kuntegowdanahalli, L., . . . Somani, N. (2025). Safety of nivolumab in treating Indian patients with non-small-cell lung carcinoma and renal cell carcinoma: A prospective multicenter study. Cancer Research, Statistics & Treatment, 8(1), 12. https://doi.org/10.4103/crst.crst_78_24

Chicago Style (17th ed.) Citation

Prabhash, Kumar, et al. "Safety of Nivolumab in Treating Indian Patients with Non-small-cell Lung Carcinoma and Renal Cell Carcinoma: A Prospective Multicenter Study." Cancer Research, Statistics & Treatment 8, no. 1 (2025): 12. https://doi.org/10.4103/crst.crst_78_24.

MLA (9th ed.) Citation

Prabhash, Kumar, et al. "Safety of Nivolumab in Treating Indian Patients with Non-small-cell Lung Carcinoma and Renal Cell Carcinoma: A Prospective Multicenter Study." Cancer Research, Statistics & Treatment, vol. 8, no. 1, 2025, p. 12, https://doi.org/10.4103/crst.crst_78_24.